51.82
price down icon0.12%   -0.06
after-market 시간 외 거래: 51.40 -0.42 -0.81%
loading
전일 마감가:
$51.88
열려 있는:
$51.57
하루 거래량:
386.97K
Relative Volume:
0.25
시가총액:
$4.13B
수익:
-
순이익/손실:
$-269.44M
주가수익비율:
-13.82
EPS:
-3.75
순현금흐름:
$-262.63M
1주 성능:
-3.32%
1개월 성능:
-4.09%
6개월 성능:
+98.09%
1년 성능:
+86.47%
1일 변동 폭
Value
$51.51
$52.32
1주일 범위
Value
$50.60
$54.99
52주 변동 폭
Value
$21.34
$58.40

Akero Therapeutics Inc Stock (AKRO) Company Profile

Name
명칭
Akero Therapeutics Inc
Name
전화
650-487-6488
Name
주소
601 GATEWAY BOULEVARD, SUITE 350, SOUTH SAN FRANCISCO, CA
Name
직원
69
Name
트위터
@akerotx
Name
다음 수익 날짜
2024-11-11
Name
최신 SEC 제출 서류
Name
AKRO's Discussions on Twitter

AKRO을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
AKRO
Akero Therapeutics Inc
51.82 4.14B 0 -269.44M -262.63M -3.75
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Akero Therapeutics Inc Stock (AKRO) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-01-30 업그레이드 BofA Securities Neutral → Buy
2025-01-27 재확인 H.C. Wainwright Buy
2024-11-18 개시 Citigroup Buy
2024-04-22 재개 BofA Securities Neutral
2023-09-19 개시 Cantor Fitzgerald Overweight
2023-08-28 개시 UBS Buy
2023-01-27 업그레이드 Morgan Stanley Equal-Weight → Overweight
2022-09-14 업그레이드 Evercore ISI In-line → Outperform
2021-10-19 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2021-09-10 개시 BofA Securities Buy
2021-02-26 개시 Guggenheim Buy
2020-09-10 개시 Morgan Stanley Overweight
2020-07-20 재확인 H.C. Wainwright Buy
2020-07-07 개시 Chardan Capital Markets Buy
2020-07-01 재확인 H.C. Wainwright Buy
2020-03-02 개시 H.C. Wainwright Buy
2020-02-10 개시 Canaccord Genuity Buy
2019-07-15 개시 Evercore ISI Outperform
2019-07-15 개시 JP Morgan Overweight
2019-07-15 개시 Jefferies Buy
2019-07-15 개시 ROTH Capital Buy
모두보기

Akero Therapeutics Inc 주식(AKRO)의 최신 뉴스

pulisher
06:26 AM

Readystate Asset Management LP Invests $4.07 Million in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

06:26 AM
pulisher
04:29 AM

Jennison Associates LLC Takes Position in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

04:29 AM
pulisher
03:03 AM

Akero Therapeutics Inc. Stock Analysis and ForecastFastest-growing stock picks - Autocar Professional

03:03 AM
pulisher
03:01 AM

Is Akero Therapeutics Inc. a good long term investmentHigh-velocity gains - Autocar Professional

03:01 AM
pulisher
02:57 AM

What drives Akero Therapeutics Inc. stock priceExponential wealth increase - Autocar Professional

02:57 AM
pulisher
Jul 22, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells $529,500.00 in Stock - MarketBeat

Jul 22, 2025
pulisher
Jul 22, 2025

Kennondale Capital Management LLC Has $571,000 Stock Holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Akero Therapeutics Inc. stockFastest-growing stock picks - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Bank of New York Mellon Corp Purchases 12,235 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jul 22, 2025
pulisher
Jul 21, 2025

Edgestream Partners L.P. Buys Shares of 6,947 Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jul 21, 2025
pulisher
Jul 20, 2025

Xponance Inc. Buys Shares of 5,565 Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jul 20, 2025
pulisher
Jul 18, 2025

257,025 Shares in Akero Therapeutics, Inc. (NASDAQ:AKRO) Purchased by Principal Financial Group Inc. - MarketBeat

Jul 18, 2025
pulisher
Jul 17, 2025

Mirum Gains 35% in 3 Months: How Should You Play the Stock? - The Globe and Mail

Jul 17, 2025
pulisher
Jul 16, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Receives $82.50 Average Price Target from Analysts - MarketBeat

Jul 16, 2025
pulisher
Jul 16, 2025

Emerald Advisers LLC Has $11.92 Million Stock Holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jul 16, 2025
pulisher
Jul 15, 2025

How Akero Therapeutics Inc. stock performs during market volatilityFree Stock Market Forecasting Tools - beatles.ru

Jul 15, 2025
pulisher
Jul 15, 2025

Emerald Mutual Fund Advisers Trust Sells 145,145 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jul 15, 2025
pulisher
Jul 14, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) CEO Andrew Cheng Sells 30,000 Shares - MarketBeat

Jul 14, 2025
pulisher
Jul 14, 2025

Learn to Evaluate (AKRO) using the Charts - news.stocktradersdaily.com

Jul 14, 2025
pulisher
Jul 13, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells $638,625.00 in Stock - MarketBeat

Jul 13, 2025
pulisher
Jul 11, 2025

Akero Therapeutics CEO Cheng sells $1.5m in stock By Investing.com - Investing.com Canada

Jul 11, 2025
pulisher
Jul 06, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) VP Patrick Lamy Sells 2,000 Shares - MarketBeat

Jul 06, 2025
pulisher
Jul 03, 2025

(AKRO) Investment Report - news.stocktradersdaily.com

Jul 03, 2025
pulisher
Jul 03, 2025

Oppenheimer & Co. Inc. Invests $297,000 in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jul 03, 2025
pulisher
Jun 30, 2025

Akero Therapeutics, Inc.(NasdaqGS: AKRO) dropped from Russell 3000 Value Index - MarketScreener

Jun 30, 2025
pulisher
Jun 23, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Akero Therapeutics, Inc. (AKRO) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

Jun 23, 2025
pulisher
Jun 23, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) CTO Scott A. Gangloff Sells 848 Shares - MarketBeat

Jun 23, 2025
pulisher
Jun 22, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Receives $82.50 Consensus Price Target from Analysts - MarketBeat

Jun 22, 2025
pulisher
Jun 20, 2025

Akero therapeutics (AKRO) SVP Lamy sells $108k in stock By Investing.com - Investing.com UK

Jun 20, 2025
pulisher
Jun 18, 2025

Akero Therapeutics (NASDAQ:AKRO) Stock Price Down 3.3%Time to Sell? - MarketBeat

Jun 18, 2025
pulisher
Jun 15, 2025

Don't Ignore The Insider Selling In Akero Therapeutics - simplywall.st

Jun 15, 2025
pulisher
Jun 15, 2025

Insider Selling: Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells 2,803 Shares of Stock - MarketBeat

Jun 15, 2025
pulisher
Jun 14, 2025

Insider Selling: Akero Therapeutics, Inc. (NASDAQ:AKRO) COO Sells 2,493 Shares of Stock - MarketBeat

Jun 14, 2025
pulisher
Jun 14, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells $127,332.00 in Stock - MarketBeat

Jun 14, 2025
pulisher
Jun 14, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) CFO Sells $151,387.96 in Stock - MarketBeat

Jun 14, 2025
pulisher
Jun 14, 2025

Rhumbline Advisers Purchases 5,001 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jun 14, 2025
pulisher
Jun 14, 2025

Millennium Management LLC Lowers Stock Holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jun 14, 2025

Akero Therapeutics Inc (AKRO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
자본화:     |  볼륨(24시간):